Global Type 1 Diabetes Market 2014-2018

Date: May 30, 2014
Pages: 85
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until January 15, 2015!
License [?]:
Publisher: Infiniti Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: GD4DC8EF77AEN
Leaflet:

Download PDF Leaflet

Global Type 1 Diabetes Market 2014-2018
About Type 1 Diabetes

Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This, in turn, hampers the body’s ability to produce insulin and disrupts blood glucose homeostasis. Type 1 diabetes T1D differs from the more common form of diabetes mellitus, Type 2 diabetes, as people with Type 2 diabetes do produce insulin. T1D accounts for only 5-15 percent of the total diabetic cases and is usually reported in children and adolescents. T1D was formerly known as juvenile diabetes. T1D management relies on providing symptomatic relief and improving quality of life.

TechNavio's analysts forecast the Global Type 1 Diabetes Market will grow at a CAGR of 6.9 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Type 1 Diabetes Market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various type 1 diabetes management drugs, which includes insulin-based replacement products and amylin analogues.

TechNavio's report, the Global Type 1 Diabetes Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Type 1 Diabetes market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
  • Americas
  • EMEA
  • APAC
Key Vendors
  • Astrazeneca plc
  • Eli Lilly and Co.
  • Novo Nordisk A/S
  • Sanofi-Aventis US LLC
Other Prominent Vendors
  • Biodel Inc.
  • Diamyd Medical AB
  • DiaVacs Inc.
  • Generex Biotechnology Corp.
  • Lexicon Pharmaceuticals Inc.
  • Macrogenics Inc.
  • MannKind Corp.
  • Osiris Therapeutics Inc.
  • Tolerion Inc.
  • XOMA Corp.
Key Market Driver
  • Increasing Global Type 1 Diabetic Population.
  • For a full, detailed list, view our report.
Key Market Challenge
  • Side Effects of Current Therapies.
  • For a full, detailed list, view our report.
Key Market Trend
  • Focus on Emerging Markets.
  • For a full, detailed list, view our report.
Key Questions Answered in this Report
  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
01. EXECUTIVE SUMMARY

02. LIST OF ABBREVIATIONS

03. SCOPE OF THE REPORT

03.1 Market Overview
03.2 Product Offerings

04. MARKET RESEARCH METHODOLOGY

04.1 Market Research Process
04.2 Research Methodology

05. INTRODUCTION

06. MARKET LANDSCAPE

06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. GLOBAL MARKET SHARE BY PRODUCTS

08. PRODUCT PORTFOLIO

09. CLINICAL PIPELINE PORTPOLIO

10. GEOGRAPHICAL SEGMENTATION

11. BUYING CRITERIA

12. MARKET GROWTH DRIVERS

13. DRIVERS AND THEIR IMPACT

14. MARKET CHALLENGES

15. IMPACT OF DRIVERS AND CHALLENGES

16. MARKET TRENDS

17. TRENDS AND THEIR IMPACT

18. VENDOR LANDSCAPE

18.1 Competitive Scenario
  18.1.1 Key News
  18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Future Vendors Expected to Tap the Market

LIST OF EXHIBITS

Exhibit 1: Market Research Methodology
Exhibit 2: Global Type 1 Diabetes Drugs Market 2013-2018 (US$ million)
Exhibit 3: Global Market Share of Diabetes Drugs 2013 (US$ million)
Exhibit 4: Global Type 1 Diabetes Market by Geographical Segmentation 2013
Exhibit 5: Incidence and Prevalence of Type1 Diabetes in Children (0-14 Years) 2013 (in thousands)
Exhibit 6: Market Share of Vendors in Global Type 1 Diabetes Market (in Percent)
Exhibit 7: Revenue Share of Novo Nordisk’s Insulin Products (in Percent)
Exhibit 8: Novo Nordisk’s Insulin Products Revenue Segmentation by Geography (in Percentage)
Exhibit 9: Geography Wise Revenue of Novo Nordisk’s Insulin Products (US$ million)
Exhibit 10: Eli Lilly’s Insulin Products Revenue Segmentation by Geography (in Percentage)
Exhibit 11: Geography Wise Revenue of Eli Lilly’s Insulin Products (US$ million)
Exhibit 12: Sanofi’s Insulin Products Revenue Segmentation by Geography (in Percentage)
Electric Motors Market in the US 2014-2018 US$ 2,000.00 May, 2014 · 54 pages
Process Plant Equipment Market in India 2014-2018 US$ 2,000.00 May, 2014 · 51 pages
Global Gluten-free Food Market 2014-2018 US$ 2,000.00 May, 2014 · 69 pages
Global Health and Wellness Food Market 2014-2018 US$ 2,000.00 May, 2014 · 78 pages

Ask Your Question

Global Type 1 Diabetes Market 2014-2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: